SG3 Management, LLC

SEC CIK: 0001630888
Latest filing: Nov 15, 2023

SEC filings (opens in a new tab)

TBPH holding history

Theravance Biopharma, Inc. in every 13F filed by SG3 Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TBPH overview All 13F holders of TBPH Full Q3 2023 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of TBPH by SG3 Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−24,800−100.0%	Sold out	Holders
Q1 2022	24,800	$237.0K	0.1%	+24,800	New	Holders
Q2 2021	0	$0	0.0%	−13,000−100.0%	Sold out	Holders
Q1 2021	13,000	$265.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.